Children and adolescents in low- and middle-income countries living with HIV showed a reduced viral load after treatment with ...
The company received $441,437 from the foundation to miniaturize its molecular point-of-care test for HIV viral load.
Add Yahoo as a preferred source to see more of our stories on Google. Enanta Pharmaceuticals reported that the Phase IIb trial failed to meet its primary endpoint. Image credit: viewimage / ...
A federally funded clinical trial suggests knowing HIV viral load (number of HIV particles in the body) doesn’t improve the number of patients seeking treatment for active HIV infection or preventive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results